| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-07 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-05 |